Teeft.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Teeft.i » - entrée « Matteo foundation »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Matrix serum levels < Matteo foundation < Matucci  Facettes :

List of bibliographic references indexed by Matteo foundation

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
003251 (2013) B. Rintelen ; J. Sautner ; K. Stingl ; N. Kalmann [Autriche] ; B. F. LeebAB0267 Does the change of questions assessing patient’s global assessment influence composite scores in rheumatoid arthritis? is there also an influence on agreement of the composite scores to a patient outcome measure like the RADAI-5?
003252 (2013) B. Rintelen ; J. Sautner ; P. M. Haindl ; H. T. Mai ; H.-P. Brezinschek [Autriche] ; B. F. LeebAB0266 Characteristics of patients according to the two 2011 ACR/EULAR proposals of remission in rheumatoid arthritis
003253 (2013) B. Rintelen ; J. Sautner ; P. M. Haindl ; H. T. Mai ; H.-P. Brezinschek [Autriche] ; B. F. LeebAB0265 RADAI-5 remission represents 2011 ACR/EULAR proposal for remission with high specificity
003254 (2013) B. HeidariAB0264 Low dose methotrexate protects rheumatoid arthritis bone mass against corticosteroid induced bone loss
003255 (2013) A. Manzo ; S. Bugatti ; F. Benaglio ; C. Klersy [Italie] ; B. Vitolo ; M. Todoerti ; G. Sakellariou ; C. Montecucco ; R. CaporaliAB0263 Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs
003258 (2013) A. L. Fedele [Italie] ; B. Tolusso [Italie] ; M. C. Totaro [Italie] ; S. L. Bosello [Italie] ; S. Canestri [Italie] ; E. Gremese [Italie] ; G. Ferraccioli [Italie]AB0262 PTPN22 1858C>T polymorphism is a negative biomarker of (eular good) response to methotrexate in a cohort of early rheumatoid arthritis
003260 (2013) A. Koenig [États-Unis] ; A. Szumski [États-Unis] ; S. Kotak [États-Unis] ; M. Stewart [États-Unis]AB0261 Profile of an under-studied rheumatoid arthritis (RA) population: characteristics of patients with moderately active rheumatoid arthritis despite methotrexate use
003262 (2013) A. Chow [Canada] ; C. Thorne [Canada] ; W. Bensen [Canada] ; D. Choquette ; E. Rampakakis [Canada] ; J. Sampalis [Canada] ; S. Otawa [Canada] ; S. Khalil [Canada]AB0260 Comparison of rheumatoid arthritis (RA) patient parameters at anti-TNF treatment initiation demonstrates wide variability over time in a large real-life cohort treated with infliximab
003263 (2013) A. S. Avdeeva ; E. N. Alexandrova ; A. A. Novikov ; E. Y. Panasyuk ; M. V. Cherkasova ; E. L. Nasonov [Russie]AB0259 The high basal level antibodies to modified citrullinated vimentin (anti-MCV) – predictive factor of response to tocilizumab therapy in rheumatoid arthritis
003266 (2013) A. A. Fathy ; S. M. Rashad ; Z. A. Selim ; D. M. Elsebaity [Égypte]AB0258 Cataract extraction (CE) and intraocular lens implantation (IOL) in patients with rheumatoid arthritis (RA)
003267 (2013) A. Skapenko [Allemagne] ; J. S. Smolen [Autriche] ; A. Kavanaugh ; S. Santra [États-Unis] ; H. Kupper [Allemagne] ; H. Schulze-Koops [Allemagne]AB0257 Genetic effects of HLA-DRB1, IL4R, and FCΓRIIB on long-term treatment responses in patients with early rheumatoid arthritis: 78-week results of optima
003269 (2013) A. Khan [Royaume-Uni] ; A. Leak [Royaume-Uni]AB0256 Sex difference in response to rituximab in rheumatoid arthritis patients
003271 (2013) A. E. Elhewala ; M. A. E.-H. Al-Toukhy ; S. A. E.-M. Ibrahim [Égypte] ; M. A. MortadaAB0255 Early rheumatoid arthritis: Diagnosis and outcome predictors
003272 (2013) Y. Savitskaya ; G. Rico ; L. Linares ; E. Delgado ; E. Estrada ; E. Martinez ; R. Tellez ; C. Ibarra [Mexique]AB0254 Clinical utility of natural angiogenin antibodies in pediatric osteosarcoma patients
003273 (2013) V. A. Malievsky ; T. V. Victorova [Russie] ; K. V. Danilko ; L. NazarovaAB0253 The association of the IL1B and TNFα gene polymorphism with juvenile arthritis
003274 (2013) O. Vougiouka [Grèce] ; T. Karpathios [Grèce] ; H. Konstantopoulos [Grèce] ; C. Bakoula [Grèce]AB0252 Traps syndrome in a three generation greek family with long lasting recurrent fevers

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Matteo foundation" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Matteo foundation" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Matteo foundation
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021